ID:TF7L2_HUMAN DESCRIPTION: RecName: Full=Transcription factor 7-like 2; AltName: Full=HMG box transcription factor 4; AltName: Full=T-cell-specific transcription factor 4; Short=T-cell factor 4; Short=TCF-4; Short=hTCF-4; FUNCTION: Participates in the Wnt signaling pathway and modulates MYC expression by binding to its promoter in a sequence-specific manner. Acts as repressor in the absence of CTNNB1, and as activator in its presence. Activates transcription from promoters with several copies of the Tcf motif 5'-CCTTTGATC-3' in the presence of CTNNB1. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7L2/TCF4 and CTNNB1. Expression of dominant-negative mutants results in cell-cycle arrest in G1. Necessary for the maintenance of the epithelial stem-cell compartment of the small intestine. SUBUNIT: Interacts with TGFB1I1 (By similarity). Interacts with CTNNB1 (via the armadillo repeat); forms stable transcription complex. Interacts with EP300. Interacts with NLK. Interacts with CCDC85B (probably through the HMG box); prevents interaction with CTNNB1. Interacts with TNIK. Interacts with MAD2L2; prevents TCF7L2/TCF4 binding to promZIPK/DAPK3oters, negatively modulating its transcriptional activity. Interacts with ZIPK/DAPK3. Interacts with XIAP/BIRC4 and TLE3. Interacts with DDIT3/CHOP. INTERACTION: P35222:CTNNB1; NbExp=27; IntAct=EBI-924724, EBI-491549; Q9UER7:DAXX; NbExp=5; IntAct=EBI-924724, EBI-77321; P14923:JUP; NbExp=13; IntAct=EBI-924724, EBI-702484; Q13761:RUNX3; NbExp=14; IntAct=EBI-924724, EBI-925990; P12956:XRCC6; NbExp=9; IntAct=EBI-924724, EBI-353208; SUBCELLULAR LOCATION: Nucleus, PML body. Note=Diffuse pattern. Colocalizes with SUMO1 and PIAS4 in a subset of PML (promyelocytic leukemia) nuclear bodies. TISSUE SPECIFICITY: Detected in epithelium from small intestine, with the highest expression at the top of the crypts and a gradient of expression from crypt to villus. Detected in colon epithelium and colon cancer, and in epithelium from mammary gland and carcinomas derived therefrom. DEVELOPMENTAL STAGE: Highly expressed in crypt regions and barely detectable in villi in epithelium from fetal small intestine at week 16. At week 22 expression in villi had increased strongly. DOMAIN: The promoter-specific activation domain interacts with the transcriptional coactivator EP300. PTM: In vitro, phosphorylated by TNIK. PTM: Phosphorylated at Thr-201 and/or Thr-212 by NLK. Phosphorylation by NLK at these sites inhibits DNA-binding by TCF7L2/TCF4, thereby preventing transcriptional activation of target genes of the canonical Wnt/beta-catenin signaling pathway. PTM: Polysumoylated. Sumoylation is enhanced by PIAS family members and desumoylation is enhanced by SENP2. Sumoylation/desumoylation regulates TCF7L2/TCF4 transcription activity in the Wnt/beta-catenin signaling pathway without altering interaction with CTNNB1 nor binding to DNA. DISEASE: Note=Constitutive activation and subsequent transactivation of target genes may lead to the maintenance of stem-cell characteristics (cycling and longevity) in cells that should normally undergo terminal differentiation and constitute the primary transforming event in colorectal cancer (CRC). DISEASE: Genetic variations in TCF7L2 are associated with susceptibility to non-insulin-dependent diabetes mellitus (NIDDM) [MIM:125853]. NIDDM is characterized by an autosomal dominant mode of inheritance, onset during adulthood and insulin resistance. SIMILARITY: Belongs to the TCF/LEF family. SIMILARITY: Contains 1 HMG box DNA-binding domain.
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on Q9NQB0
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Molecular Function: GO:0000978 RNA polymerase II core promoter proximal region sequence-specific DNA binding GO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding GO:0001103 RNA polymerase II repressing transcription factor binding GO:0003677 DNA binding GO:0003700 transcription factor activity, sequence-specific DNA binding GO:0005515 protein binding GO:0008013 beta-catenin binding GO:0008134 transcription factor binding GO:0019901 protein kinase binding GO:0035257 nuclear hormone receptor binding GO:0043565 sequence-specific DNA binding GO:0044212 transcription regulatory region DNA binding GO:0045295 gamma-catenin binding GO:0070016 armadillo repeat domain binding
Biological Process: GO:0000122 negative regulation of transcription from RNA polymerase II promoter GO:0001568 blood vessel development GO:0006351 transcription, DNA-templated GO:0006355 regulation of transcription, DNA-templated GO:0006357 regulation of transcription from RNA polymerase II promoter GO:0007050 cell cycle arrest GO:0007223 Wnt signaling pathway, calcium modulating pathway GO:0008283 cell proliferation GO:0009749 response to glucose GO:0010909 positive regulation of heparan sulfate proteoglycan biosynthetic process GO:0016055 Wnt signaling pathway GO:0031016 pancreas development GO:0032024 positive regulation of insulin secretion GO:0032092 positive regulation of protein binding GO:0032350 regulation of hormone metabolic process GO:0042593 glucose homeostasis GO:0043433 negative regulation of sequence-specific DNA binding transcription factor activity GO:0043570 maintenance of DNA repeat elements GO:0044334 canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition GO:0045444 fat cell differentiation GO:0045892 negative regulation of transcription, DNA-templated GO:0045944 positive regulation of transcription from RNA polymerase II promoter GO:0046827 positive regulation of protein export from nucleus GO:0048625 myoblast fate commitment GO:0048660 regulation of smooth muscle cell proliferation GO:0051897 positive regulation of protein kinase B signaling GO:0060070 canonical Wnt signaling pathway GO:0090090 negative regulation of canonical Wnt signaling pathway GO:1904837 beta-catenin-TCF complex assembly GO:2000675 negative regulation of type B pancreatic cell apoptotic process GO:2001237 negative regulation of extrinsic apoptotic signaling pathway